50 – Updated American Heart Association/American College of Cardiology; European Society of Hypertension/International Society of Hypertension Guidelines

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/B978-0-323-42973-3.00050-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• A Randomized Trial of Intensive versus Standard Blood-Pressure Control.

  2017cited by this paper
• Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis.

  2016cited by this paper
• Effects of blood pressure-lowering on outcome incidence in hypertension: 5. Head-to-head comparisons of various classes of antihypertensive drugs – overview and meta-analyses

  2015cited by this paper
• Adherence With Antihypertensive Drug Therapy and the Risk of Heart Failure in Clinical Practice

  2015cited by this paper
• Clinical value of ambulatory blood pressure: evidence and limits.

  2015cited by this paper
• Trends in Blood Pressure Among Adults With Hypertension: United States, 2003 to 2012

  2015cited by this paper
• Effects of blood pressure lowering on outcome incidence in hypertension: 4. Effects of various classes of antihypertensive drugs – Overview and meta-analyses

  2015cited by this paper
• Treatment of Hypertension in Patients With Coronary Artery Disease: A Scientific Statement From the American Heart Association, American College of Cardiology, and American Society of Hypertension

  2015cited by this paper
• Factors involved in the discontinuation of antihypertensive drug therapy: an analysis from real life data

  2014cited by this paper
• Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data.

  2014cited by this paper
• 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8).

  2014cited by this paper
• Initial Combination Therapy Reduces the Risk of Cardiovascular Events in Hypertensive Patients: A Matched Cohort Study

  2013cited by this paper
• Individualization of Antihypertensive Drug Treatment

  2013cited by this paper
• Measuring the global burden of disease.

  2013cited by this paper
• Initial Monotherapy and Combination Therapy and Hypertension Control the First Year

  2012cited by this paper
• Longing for clinical excellence: a critical outlook into the NICE recommendations on hypertension management – is nice always good?

  2012cited by this paper
• Systematic Review: Blood Pressure Target in Chronic Kidney Disease and Proteinuria as an Effect Modifier

  2011cited by this paper
• Cardiovascular Protection by Initial and Subsequent Combination of Antihypertensive Drugs in Daily Life Practice

  2011cited by this paper
• Changes in albuminuria predict mortality and morbidity in patients with vascular disease.

  2011cited by this paper
• Blood Pressure Targets Recommended by Guidelines and Incidence of Cardiovascular and Renal Events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)

  2011cited by this paper
• Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients

  2011cited by this paper
• Risk prediction is improved by adding markers of subclinical organ damage to SCORE.

  2010cited by this paper
• US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

  2010cited by this paper
• Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies

  2009cited by this paper
• Scientific evidence underlying the ACC/AHA clinical practice guidelines.

  2009cited by this paper
• Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document.

  2009cited by this paper
• Choice of antihypertensive drugs in the European Society of Hypertension-European Society of Cardiology guidelines: specific indications rather than ranking for general usage.

  2008cited by this paper
• Effects of different regimens to lower blood pressure on major cardiovascular events in older and younger adults: meta-analysis of randomised trials

  2008cited by this paper
• Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.

  2008cited by this paper
• 2013 ESH/ESC Guidelines for the management of arterial hypertension

  2007cited by this paper
• 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)

  2007cited by this paper
• 2007 ESH-ESC Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

  2007cited by this paper
• Relationship of Office, Home, and Ambulatory Blood Pressure to Blood Glucose and Lipid Variables in the PAMELA Population

  2005cited by this paper
• Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials

  2005cited by this paper
• Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial.

  2005cited by this paper
• Hot papers : Comparative genomics on the rise

  2005cited by this paper
• The Burden of Adult Hypertension in the United States 1999 to 2000: A Rising Tide

  2004cited by this paper
• The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents

  2004cited by this paper
• Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project.

  2003cited by this paper
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.

  2003cited by this paper
• Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials.

  2003cited by this paper
• Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

  2003cited by this paper
• Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials

  2003cited by this paper
• 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension.

  2003cited by this paper
• Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

  2002cited by this paper
• Acceptance of guideline recommendations and perceived implementation of coronary heart disease prevention among primary care physicians in five European countries: the Reassessing European Attitudes about Cardiovascular Treatment (REACT) survey.

  2002cited by this paper
• Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial.

  2002cited by this paper
• Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies.

  2002cited by this paper
• Impact of High-Normal Blood Pressure on the Risk of Cardiovascular Disease

  2001cited by this paper
• Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients.

  2000cited by this paper
• Risk stratification in hypertension: new insights from the Framingham Study.

  2000cited by this paper
• Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group.

  2000cited by this paper
• Optimisation of antihypertensive treatment by crossover rotation of four major classes.

  1999cited by this paper
• 1999 World Health Organization-International Society of Hypertension Guidelines for the Management of Hypertension. Guidelines Subcommittee.

  1999cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group.

  1998cited by this paper
• The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure.

  1997cited by this paper
• The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease

  1994cited by this paper
• National High Blood Pressure Education Program Working Group Report on Hypertension in Diabetes

  1994cited by this paper
• National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly

  1994cited by this paper
• Changes in hypertension awareness, treatment, and control rates. 20-year trend data.

  1993cited by this paper
• 1993 Guidelines for the Management of Mild Hypertension: Memorandum From a World Health Organization/ International Society of Hypertension Meeting

  1993cited by this paper
• Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group.

  1989cited by this paper
• The 1988 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

  1988cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• NHLBI workshop on renovascular disease. Summary report and recommendations.

  1985cited by this paper
• Hypertension prevalence and the status of awareness, treatment, and control in the United States. Final report of the Subcommittee on Definition and Prevalence of the 1984 Joint National Committee.

  1985cited by this paper
• The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure.

  1984cited by this paper
• Treatment of mild hypertension: results of a ten-year intervention trial.

  1977cited by this paper
• The report on detection, evaluation, and treatment of high blood pressure.

  1977cited by this paper
• Letter: Immunotherapy for colorectal cancer.

  1976cited by this paper
• Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg.

  1967cited by this paper
• FRACTURE OF THE FEMORAL NECK.

  1964cited by this paper

• Commentary on Fanaroff et al., Levels of Evidence Supporting American College of Cardiology/American Heart Association and European Society of Cardiology Guidelines, 2008-2018. JAMA. 2019;321(11):1069-80

  2019cites this paper